Private Portfolio Partners LLC purchased a new stake in shares of AmerisourceBergen Corp. (NYSE:ABC) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 2,382 shares of the company’s stock, valued at approximately $203,000.

Several other institutional investors and hedge funds have also modified their holdings of ABC. Motco purchased a new stake in AmerisourceBergen in the second quarter worth $26,000. Pathstone Family Office LLC increased its position in AmerisourceBergen by 67.7% in the second quarter. Pathstone Family Office LLC now owns 312 shares of the company’s stock worth $27,000 after buying an additional 126 shares during the last quarter. Rational Advisors LLC increased its position in AmerisourceBergen by 1,627.3% in the first quarter. Rational Advisors LLC now owns 380 shares of the company’s stock worth $30,000 after buying an additional 358 shares during the last quarter. Citizens Financial Group Inc RI increased its position in AmerisourceBergen by 316.5% in the second quarter. Citizens Financial Group Inc RI now owns 454 shares of the company’s stock worth $39,000 after buying an additional 345 shares during the last quarter. Finally, Winslow Evans & Crocker Inc. increased its position in AmerisourceBergen by 212.2% in the second quarter. Winslow Evans & Crocker Inc. now owns 718 shares of the company’s stock worth $62,000 after buying an additional 488 shares during the last quarter. 65.95% of the stock is owned by institutional investors.

A number of analysts have issued reports on ABC shares. Morgan Stanley decreased their target price on AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, September 6th. ValuEngine downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Tuesday, August 6th. TheStreet raised AmerisourceBergen from a “c+” rating to a “b” rating in a research report on Thursday, August 1st. Deutsche Bank started coverage on AmerisourceBergen in a research report on Thursday, September 12th. They issued a “hold” rating and a $91.00 target price for the company. Finally, Zacks Investment Research raised AmerisourceBergen from a “hold” rating to a “buy” rating and set a $89.00 target price for the company in a research report on Wednesday, June 12th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and four have given a buy rating to the stock. AmerisourceBergen presently has a consensus rating of “Hold” and a consensus price target of $87.38.

In related news, EVP John G. Chou sold 13,997 shares of AmerisourceBergen stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $86.29, for a total transaction of $1,207,801.13. Following the completion of the sale, the executive vice president now owns 65,782 shares of the company’s stock, valued at $5,676,328.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Steven H. Collis sold 19,905 shares of AmerisourceBergen stock in a transaction on Monday, September 9th. The shares were sold at an average price of $86.89, for a total value of $1,729,545.45. Following the sale, the chief executive officer now directly owns 154,484 shares of the company’s stock, valued at approximately $13,423,114.76. The disclosure for this sale can be found here. Insiders sold 78,389 shares of company stock valued at $6,947,790 over the last ninety days. Corporate insiders own 27.80% of the company’s stock.

Shares of AmerisourceBergen stock traded up $1.89 during trading hours on Thursday, reaching $84.89. The company had a trading volume of 55,610 shares, compared to its average volume of 1,175,055. AmerisourceBergen Corp. has a one year low of $69.36 and a one year high of $94.85. The business has a fifty day simple moving average of $85.87 and a 200 day simple moving average of $81.97. The company has a debt-to-equity ratio of 1.40, a current ratio of 0.95 and a quick ratio of 0.56. The firm has a market cap of $17.44 billion, a PE ratio of 13.09, a price-to-earnings-growth ratio of 1.50 and a beta of 1.00.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.76 EPS for the quarter, topping the Zacks’ consensus estimate of $1.62 by $0.14. AmerisourceBergen had a return on equity of 47.88% and a net margin of 0.54%. The firm had revenue of $45.24 billion during the quarter, compared to analyst estimates of $45.15 billion. During the same period last year, the company earned $1.54 earnings per share. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, research analysts forecast that AmerisourceBergen Corp. will post 7.05 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 3rd. Stockholders of record on Monday, August 19th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date of this dividend was Friday, August 16th. AmerisourceBergen’s payout ratio is currently 24.65%.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Read More: What is a Derivative?

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.